Download PDF
Semin Liver Dis 2008; 28(2): 142-152
DOI: 10.1055/s-2008-1073114
© Thieme Medical Publishers

Etiologies of Acute Liver Failure

William M. Lee1
  • 1Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas
Further Information

Publication History

Publication Date:
02 May 2008 (online)

    Permissions and Reprints

ABSTRACT

Acute liver failure is present when any type of rapid-onset liver insult results in a common systemic pathophysiologic picture: altered mental status, vasodilation, renal and pulmonary failure, frequent infection, and poor outcome without transplantation. Identifying which of the many different causes is a first step in understanding prognosis and options for treatment. However, identifying the correct cause can be difficult and sometimes impossible. Any discussion of etiologies must take a historical perspective; there have been several evolving trends nationally and internationally over the past three decades. Etiologies also vary worldwide with considerable differences apparent between Western countries and the developing world. In Europe and North America a large proportion of cases are due to acetaminophen and to idiosyncratic drug reactions, whereas reports from emerging countries in Asia and Africa feature viral illnesses, particularly hepatitis B and E. Determining etiology is important for two reasons: specific antidotes or therapies may be indicated once the diagnosis is known, and knowing the cause provides a reasonably valid guide to predicting outcome.

KEYWORDS

Acute liver failure - acetaminophen - hepatitis - drug-induced liver injury - Budd-Chiari syndrome - Wilson's disease

REFERENCES

  • 1 Ritt D J, Whelan G, Werner D J, Eigenbrodt E H, Schenker S, Combes B. Acute hepatic necrosis with stupor or coma: an analysis of thirty-one patients.  Medicine. 1969;  48 151-172
    PubMedGoogle Scholar
  • 2 Rakela J, Mosley J W, Edwards V M. and the Acute Hepatic Failure Study Group . A double-blinded, randomized trial of hydrocortisone in acute hepatic failure.  Dig Dis Sci. 1991;  36 1223-1228
    CrossrefPubMedGoogle Scholar
  • 3 Schiødt F V, Atillasoy E, Shakil A O et al.. Etiology and outcome for 295 patients with acute liver failure in the United States.  Liver Transpl Surg. 1999;  5 29-34
    CrossrefPubMedGoogle Scholar
  • 4 Shakil A O, Kramer D, Mazariegos G V et al.. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria.  Liver Transpl. 2000;  6 163-169
    PubMedGoogle Scholar
  • 5 Ostapowicz G, Fontana R J, Schiødt F V et al.. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.  Ann Intern Med. 2002;  137 947-954
    CrossrefPubMedGoogle Scholar
  • 6 Escorsell A, Mas A, de la Mata M. and the Spanish Group for the Study of Acute Liver Failure . Acute liver failure in Spain: analysis of 267 cases.  Liver Transpl. 2007;  13 1389-1395
    CrossrefPubMedGoogle Scholar
  • 7 Schiødt F V, Lee W M. Drug-induced liver injury. In: Yamada Atlas of Gastroenterology and Hepatology. 4th ed. Philadelphia; Lippincott Williams and Wilkins 2008: 637-640
    Google Scholar
  • 8 Acharya S K, Dasarathy S, Kumer T L et al.. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.  Hepatology. 1996;  23 1448-1455
    CrossrefPubMedGoogle Scholar
  • 9 Jilani N, Das B C, Husain S A et al.. Hepatitis E virus infection and fulminant hepatic failure during pregnancy.  J Gastroenterol Hepatol. 2007;  22 676-682
    CrossrefPubMedGoogle Scholar
  • 10 Proceedings of the Food and Drug Administration Nonprescription Drugs Advisory Committee meeting; September 19, 2002 Silver Spring, MD; Testimony of Parivash Nourjah, Ph.D. http://Available at: www.fda.gov/ohrms/dockets/ac/cder02.htm#NonprescriptionDrugs Accessed March 31, 2008
  • 11 Larson A M, Polson J, Fontana R J and the Acute Liver Failure Study Group et al.. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.  Hepatology. 2005;  42 1364-1372
    CrossrefPubMedGoogle Scholar
  • 12 http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/092007/407652/article.pdf Accessed March 31, 2008
  • 13 Bower W A, Johns M, Margolis H S, Williams I T, Bell B P. Population-based surveillance for acute liver failure.  Am J Gastroenterol. 2007;  102 2459-2463
    CrossrefPubMedGoogle Scholar
  • 14 Davern II T J, James L P, Hinson J A and the Acute Liver Failure Study Group et al.. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.  Gastroenterology. 2006;  130 687-694
    CrossrefPubMedGoogle Scholar
  • 15 James L P, Alonso E M, Hynan L S and the Pediatric Acute Liver Failure Study Group et al.. Detection of acetaminophen-protein adducts in children with acute liver failure of indeterminate cause.  Pediatrics. 2006;  118 e676-e681
    CrossrefPubMedGoogle Scholar
  • 16 Bertholf R L, Johannsen L M, Bazooband A, Mansouri V. False-positive acetaminophen results in a hyperbilirubinemic patient.  Clin Chem. 2003;  49 695-698
    CrossrefPubMedGoogle Scholar
  • 17 Beuhler M C, Curry S C. False positive acetaminophen levels associated with hyperbilirubinemia.  Clin Toxicol (Phila). 2005;  43 167-170 , erratum 325
    PubMedGoogle Scholar
  • 18 Hawton K, Townsend E, Deeks J et al.. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study.  BMJ. 2001;  322 1203-1207
    CrossrefPubMedGoogle Scholar
  • 19 Sheen C L, Dillon J F, Bateman D N et al.. Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, aspirin and ibuprofen.  Pharmacoepidemiol Drug Saf. 2002;  11 329-331
    CrossrefPubMedGoogle Scholar
  • 20 Lee W M. Acetaminophen toxicity: changing perceptions of a social/medical issue.  Hepatology. 2007;  46 966-970
    CrossrefPubMedGoogle Scholar
  • 21 Department of Health and Human Services .Food and Drug Administration 21 CFR Parts 201 and 343 [Docket No. 1977N-0094L] RIN 0910-AF36. Internal Analgesic, Antipyretic, and Anti-rheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling. Available at: http://www.accessdata.fda.gov/scripts/oc/ohrms/frbydocket.cfm Accessed March 31, 2008
    Google Scholar
  • 22 Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury.  Semin Liver Dis. 2002;  22 137-144
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Kaplowitz N. Idiosyncratic drug hepatotoxicity.  Nat Rev Drug Discov. 2005;  4 489-499
    CrossrefPubMedGoogle Scholar
  • 24 Chang C Y, Schiano T D. Review article: drug hepatotoxicity.  Aliment Pharmacol Ther. 2007;  25 1135-1151
    CrossrefPubMedGoogle Scholar
  • 25 Navarro V J, Senior J R. Drug-related hepatotoxicity.  N Engl J Med. 2006;  354 731-739
    CrossrefPubMedGoogle Scholar
  • 26 Fuchs S, Simon Z, Brezis M. Fatal hepatic failure associated with ciprofloxacin.  Lancet. 1994;  343 738-739
    PubMedGoogle Scholar
  • 27 Clay K D, Hanson J S, Pope S D, Rissmiller R W, Purdum III P P, Banks P M. Brief communication: severe hepatotoxicity of telithromycin-three case reports and literature review.  Ann Intern Med. 2006;  144 415-420
    CrossrefPubMedGoogle Scholar
  • 28 Taylor R M, Davern T J, Munoz S et al.. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes.  Hepatology. 2006;  44 1589-1597
    CrossrefPubMedGoogle Scholar
  • 29 Sookoian S. Liver disease during pregnancy: acute viral hepatitis.  Ann Hepatol. 2006;  5 231-236
    PubMedGoogle Scholar
  • 30 Ikeda K, Shiga Y, Takahashi A et al.. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.  Leuk Lymphoma. 2006;  47 155-157
    CrossrefPubMedGoogle Scholar
  • 31 Ozasa A, Tanaka Y, Orito E et al.. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.  Hepatology. 2006;  44 326-334
    CrossrefPubMedGoogle Scholar
  • 32 Yeo W, Chan P K, Zhong S et al.. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.  J Med Virol. 2000;  62 299-307
    CrossrefPubMedGoogle Scholar
  • 33 Tillmann H L, Hadem J, Leifeld L et al.. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.  J Viral Hepat. 2006;  13 256-263
    CrossrefPubMedGoogle Scholar
  • 34 Reshef R, Sbeit W, Tur-Kaspa R. Lamivudine in the treatment of acute hepatitis B.  N Engl J Med. 2000;  343 1123-1124
    CrossrefPubMedGoogle Scholar
  • 35 Kumar M, Satapathy S, Monga R et al.. A randomized controlled trial of lamivudine to treat acute hepatitis B.  Hepatology. 2007;  45 97-101
    CrossrefPubMedGoogle Scholar
  • 36 Seremba E, Sanders C, Jain M and the Acute Liver Failure Study Group et al. Use of nucleoside analogues in HBV-related acute liver failure.  Hepatology. 2007;  46(suppl) 276A
    PubMedGoogle Scholar
  • 37 Teo E K, Ostapowicz G A, Hussain M, Lee W M, Fontana R J, Lok A SF. and US Acute Liver Failure Study Group . Hepatitis B infection in patients with acute liver failure in the United States.  Hepatology. 2001;  33 972-976
    CrossrefPubMedGoogle Scholar
  • 38 Umemura T, Tanaka E, Ostapowicz G et al.. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, aplastic anemia and acute and chronic non-A-E hepatitis.  J Infect Dis. 2003;  188 1545-1552
    CrossrefPubMedGoogle Scholar
  • 39 Lee W M, Brown K E, Young N S and the Acute Liver Failure Study Group et al.. Brief report: no evidence for hepatitis E or parvovirus B19 infection in patients with acute liver failure.  Dig Dis Sci. 2006;  51 1712-1715
    CrossrefPubMedGoogle Scholar
  • 40 Ichai P, Afonso A M, Sebagh M et al.. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis.  Liver Transpl. 2005;  11 1550-1555
    CrossrefPubMedGoogle Scholar
  • 41 Levitsky J, Thadareddy A, Lakeman F A et al.. Herpes simplex virus in acute liver failure.  Gastroenterology. 2007;  132(suppl 2) A-752
    PubMedGoogle Scholar
  • 42 Nakazawa H, Ito T, Makashima H et al.. Adenovirus fulminant hepatic failure: disseminated adenoviral disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia.  Intern Med. 2006;  45 975-980
    CrossrefPubMedGoogle Scholar
  • 43 Ferrari R, Pappas G, Agostinelli D et al.. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the “acute” type.  QJM. 2004;  97 407-412
    CrossrefPubMedGoogle Scholar
  • 44 Kessler W R, Cummings O W, Eckert G, Chalasani N, Lumeng L, Kwo P Y. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.  Clin Gastroenterol Hepatol. 2004;  2 625-631
    CrossrefPubMedGoogle Scholar
  • 45 Sharp J R, Ishak K G, Zimmerman H J. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin.  Ann Intern Med. 1980;  92 14-19
    CrossrefPubMedGoogle Scholar
  • 46 Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation.  Am J Gastroenterol. 2000;  95 560-561
    PubMedGoogle Scholar
  • 47 Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline-induced autoimmune hepatitis and systemic lupus erythematous-like syndrome.  BMJ. 1996;  312 169-172
    CrossrefPubMedGoogle Scholar
  • 48 Misdraji J, Thiim M, Graeme-Cook F M. Autoimmune hepatitis with centrilobular necrosis.  Am J Surg Pathol. 2004;  28 471-478
    CrossrefPubMedGoogle Scholar
  • 49 Menon K VN, Shah V, Kamath P. The Budd-Chiari syndrome.  N Engl J Med. 2004;  350 578-585
    CrossrefPubMedGoogle Scholar
  • 50 Kuo P C, Johnson L B, Hastings G et al.. Fulminant hepatic failure from the Budd-Chiari syndrome: a bridge to transplantation with transjugular intrahepatic portosystemic shunt.  Transplantation. 1996;  62 294-296
    CrossrefPubMedGoogle Scholar
  • 51 Ryu R K, Durham J D, Krysl J et al.. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome.  J Vasc Interv Radiol. 1999;  10 799-805
    CrossrefPubMedGoogle Scholar
  • 52 Shrestha R, Durham J, Wachs M et al.. Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome.  Am J Gastroenterol. 1997;  92 2304-2306
    PubMedGoogle Scholar
  • 53 Ockner S A, Brunt E M, Cohn S M, Krul E S, Hanto D W, Peters M G. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation.  Hepatology. 1990;  11 59-64
    CrossrefPubMedGoogle Scholar
  • 54 Halim A, Kanayama N, El Maradny E et al.. A study in cases of HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) and acute fatty liver of pregnancy.  Gynecol Obstet Invest. 1996;  41 106-112
    PubMedGoogle Scholar
  • 55 Lindheimer M D. Unraveling the mysteries of preeclampsia.  Am J Obstet Gynecol. 2005;  193 3-4
    CrossrefPubMedGoogle Scholar
  • 56 Levine R J, Maynard S E, Qian C et al.. Circulating angiogenic factors and the risk of preeclampsia.  N Engl J Med. 2004;  350 672-683
    CrossrefPubMedGoogle Scholar
  • 57 Bacq Y. Acute fatty liver of pregnancy.  Semin Perinatol. 1998;  22 134-140
    CrossrefPubMedGoogle Scholar
  • 58 Shaver W A, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease.  Hepatology. 1986;  6 859-863
    CrossrefPubMedGoogle Scholar
  • 59 Berman D H, Leventhal R I, Gavaler J S, Cadoff E M, Van Thiel D H. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure.  Gastroenterology. 1991;  100 1129-1134
    PubMedGoogle Scholar
  • 60 Roberts E A, Schilsky M L. A practice guideline on Wilson disease.  Hepatology. 2003;  37 1475-1492
    CrossrefPubMedGoogle Scholar
  • 61 Sallie R, Katsiyiannakis L, Baldwin D et al.. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure.  Hepatology. 1992;  16 1206-1211
    PubMedGoogle Scholar
  • 62 Berman D H, Leventhal R I, Gavaler J S, Cadoff E M, Van Thiel D H. Clinical differentiation of fulminant wilsonian hepatitis from other causes of hepatic failure.  Gastroenterology. 1991;  100 1129-1134
    PubMedGoogle Scholar
  • 63 Steindl P, Ferenci P, Dienes H P et al.. Wilson's disease in patients presenting with liver disease: a diagnostic challenge.  Gastroenterology. 1997;  113 212-218
    CrossrefPubMedGoogle Scholar
  • 64 Jhang J S, Schilsky M L, Lefkowitch J H, Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease.  J Clin Apher. 2007;  22 10-14
    CrossrefPubMedGoogle Scholar
  • 65 Asfaha S, Almansori M, Qarni U, Gutfreund K S. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease.  J Clin Apher. 2007;  22 295-298
    CrossrefPubMedGoogle Scholar
  • 66 Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.  Gut. 1998;  42 576-580
    CrossrefPubMedGoogle Scholar
  • 67 Agarwal K, Jones D E, Burt A D, Hudson M, James O F. Metastatic breast carcinoma presenting as acute liver failure and portal hypertension.  Am J Gastroenterol. 2002;  97 750-751
    CrossrefPubMedGoogle Scholar
  • 68 Rubio S, Barbero-Villares A, Reina T, Nieto S, Mendoza J, García-Buey L. Rapidly-progressive liver failure secondary to melanoma infiltration.  Gastroenterol Hepatol. 2005;  28 619-621
    PubMedGoogle Scholar
  • 69 Bhat Y M, Krasinskas A, Craig F E, Shaw-Stiffel T A. Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy.  Dig Dis Sci. 2006;  51 63-67
    CrossrefPubMedGoogle Scholar
  • 70 Cameron A M, Truty J, Truell J et al.. Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy.  Transplantation. 2005;  80 993-996
    CrossrefPubMedGoogle Scholar
  • 71 Garcin J M, Bronstein J A, Cremades S, Courbin P, Cointet F. Acute liver failure is frequent during heat stroke.  World J Gastroenterol. 2008;  14 158-159
    PubMedGoogle Scholar
  • 72 Hadad E, Ben-Ari Z, Heled Y, Moran D S, Shani Y, Epstein Y. Liver transplantation in exertional heat stroke: a medical dilemma.  Intensive Care Med. 2004;  30 1474-1478
    PubMedGoogle Scholar
  • 73 Broessner G, Beer R, Franz G et al.. Case report: severe heat stroke with multiple organ dysfunction-a novel intravascular treatment approach.  Crit Care. 2005;  9 R498-R501
    PubMedGoogle Scholar
  • 74 Berger J, Hart J, Millis M, Baker A L. Fulminant hepatic failure from heat stroke requiring liver transplantation.  J Clin Gastroenterol. 2000;  30 429-431
    CrossrefPubMedGoogle Scholar
  • 75 Polson J, Lee W M. AASLD position paper: acute liver failure.  Hepatology. 2005;  41 1179-1197
    CrossrefPubMedGoogle Scholar
  • 76 Bernal W, Ma Y, Smith H M, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study.  J Hepatol. 2007;  47 664-670
    CrossrefPubMedGoogle Scholar
  • 77 Ichai P, Duclos-Vallée J C, Guettier C et al.. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.  Liver Transpl. 2007;  13 996-1003
    CrossrefPubMedGoogle Scholar
  • 78 Czaja A J. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation.  Liver Transpl. 2007;  13 953-955
    CrossrefPubMedGoogle Scholar
  • 79 Rubio-Tapia A, Murray J A. The liver in celiac disease.  Hepatology. 2007;  46 1650-1658
    CrossrefPubMedGoogle Scholar
  • 80 Ojetti V, Fini L, Zileri Dal Verme L, Migneco A, Pola P, Gasbarrini A. Acute cryptogenic liver failure in an untreated coeliac patient: a case report.  Eur J Gastroenterol Hepatol. 2005;  17 1119-1121
    CrossrefPubMedGoogle Scholar
  • 81 Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort.  Arch Intern Med. 2003;  163 1566-1572
    CrossrefPubMedGoogle Scholar
  • 82 Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease.  Clin Gastroenterol Hepatol. 2004;  2 107-112
    CrossrefPubMedGoogle Scholar

William M LeeM.D. F.A.C.P. 

Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center

5959 Harry Hines Boulevard, Suite 420, Dallas, TX 75390-8887

Email: william.lee@utsouthwestern.edu

      >